RICCI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 18.011
AS - Asia 2.664
EU - Europa 1.875
SA - Sud America 425
AF - Africa 320
OC - Oceania 238
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.538
Nazione #
US - Stati Uniti d'America 17.860
SG - Singapore 947
CN - Cina 484
BR - Brasile 320
DE - Germania 315
IN - India 252
GB - Regno Unito 240
IT - Italia 234
AU - Australia 232
HK - Hong Kong 225
UA - Ucraina 218
IE - Irlanda 208
RU - Federazione Russa 188
ID - Indonesia 175
VN - Vietnam 116
FR - Francia 109
SE - Svezia 87
MX - Messico 76
KR - Corea 72
PL - Polonia 70
PK - Pakistan 59
FI - Finlandia 57
CA - Canada 51
GH - Ghana 51
NG - Nigeria 51
ZA - Sudafrica 44
KE - Kenya 40
TR - Turchia 38
EG - Egitto 37
MY - Malesia 34
PH - Filippine 34
ET - Etiopia 32
NL - Olanda 32
TW - Taiwan 32
JP - Giappone 26
AR - Argentina 23
BD - Bangladesh 23
IQ - Iraq 22
EC - Ecuador 20
SA - Arabia Saudita 19
BE - Belgio 18
IR - Iran 17
ES - Italia 14
CL - Cile 13
MU - Mauritius 13
AT - Austria 12
CO - Colombia 12
NP - Nepal 12
KG - Kirghizistan 11
VE - Venezuela 11
MA - Marocco 10
PE - Perù 10
TH - Thailandia 10
LT - Lituania 9
MG - Madagascar 9
NO - Norvegia 9
PT - Portogallo 9
RO - Romania 9
UG - Uganda 9
IL - Israele 7
UZ - Uzbekistan 7
EE - Estonia 6
KH - Cambogia 6
PY - Paraguay 6
ZM - Zambia 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
JO - Giordania 5
MW - Malawi 5
NZ - Nuova Zelanda 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CM - Camerun 4
EU - Europa 4
GR - Grecia 4
GT - Guatemala 4
LV - Lettonia 4
MM - Myanmar 4
NI - Nicaragua 4
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
PA - Panama 3
QA - Qatar 3
TN - Tunisia 3
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
DM - Dominica 2
JM - Giamaica 2
MO - Macao, regione amministrativa speciale della Cina 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TZ - Tanzania 2
UY - Uruguay 2
YE - Yemen 2
Totale 23.521
Città #
Woodbridge 4.669
Wilmington 4.383
Houston 4.363
Singapore 539
Fairfield 506
Ann Arbor 393
Chandler 377
Ashburn 358
Seattle 244
Cambridge 197
Beijing 196
Dublin 193
Hong Kong 185
Jacksonville 184
Medford 160
Dearborn 140
New York 128
Perth 91
Los Angeles 86
Rome 85
Santa Clara 85
The Dalles 73
Lawrence 72
Boardman 71
Zhengzhou 53
Moscow 50
Kraków 49
Ho Chi Minh City 47
Munich 43
Buffalo 40
Melbourne 39
Accra 36
Nairobi 35
São Paulo 35
Chennai 33
Jakarta 32
San Diego 32
Milan 31
Dallas 30
Sydney 30
Council Bluffs 26
Mülheim 26
Chicago 24
Shanghai 24
London 22
Malang 21
Menlo Park 21
San Francisco 20
Waurn Ponds 20
Hanoi 19
Mexico City 19
Guangzhou 18
Kuala Lumpur 18
Montreal 18
Tokyo 18
Brussels 17
Cairo 17
Hyderabad 17
Manchester 16
Nuremberg 16
Bodorgan 15
Lagos 15
Phoenix 15
Riyadh 15
Karachi 14
Lahore 14
Nanjing 14
Bengaluru 13
Denpasar 13
Johannesburg 13
Rio de Janeiro 13
Aksum 12
Birmingham 12
Boston 12
Delhi 12
Kansas City 12
Pune 12
Redondo Beach 12
Redwood City 12
Abuja 11
Kolkata 11
Palo Alto 11
Port Louis 11
Taipei 11
Baghdad 10
Bandung 10
Belo Horizonte 10
Brisbane 10
Durban 10
Fortaleza 10
Istanbul 10
Kathmandu 10
Lucknow 10
Mumbai 10
Seoul 10
Stockholm 10
Toronto 10
Warsaw 10
Antananarivo 9
Armidale 9
Totale 19.253
Nome #
A literature review of hypertensive retinopathy: systemic correlations and new technologies 2.124
Validity and limitations of the Nidek NT-4000 non-contact tonometer: a clinical study 499
Electro-oculography in pigment dispersion syndrome 478
Review of nutrient actions on age-related macular degeneration 478
Visual disability and quality of life in glaucoma patients 477
Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry. 469
Clusterin in stool: a new biomarker for colon cancer screening? 465
Age-related macular degeneration: insights into inflammatory genes 462
Automatic Segmentation of Posterior Pole Retinal Layers In Patients with Early Stage Glaucoma Using Spectral Domain Optical Coherence Tomography 452
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 451
Age-specific changes in the prevalence and management of optically correctable visual impairment between 1988 and 2000: the Ponza Eye Study 442
Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization 442
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 440
CLU "in and out": looking for a link. 436
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks 435
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 434
The 12-year Incidence of Glaucoma and Glaucoma-related Visual Field Loss in Italy: The Ponza Eye Study 432
Prevalence of blindness and low vision in an Italian population: A comparison with other European studies 426
Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab 425
Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy 424
Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinpathy (AZOOR) with adalimumab (Humira™). 418
Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration 414
Age-specific changes in the prevalence of best-corrected visual impairment in an italian population 412
Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy 411
Low contrast visual acuity in pseudophakic patients implanted with an anterior surface modified prolate intraocular lens 409
Evaluation of pupillary response to light in patients with glaucoma: a study using computerized pupillometry 409
Incidence of visual loss in the Ponza Eye Study, Italy 405
Nationwide incidence of endophthalmitis among the general population and the subjects at risk of endophthalmitis in Italy 398
Prevalence and risk factors of vision impairment among children of employees of Telecom, Italy. 398
Clusterin in stool: a new biomarker for colon cancer screening? 393
Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol. 1999 Jun;6(2):95-103. 393
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 393
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 392
CLU "in and out": looking for a link 389
ICGA Guided Low-fluence Photodynamic Therapy Combined With PRN Ranibizumab For Active Polypoidal Choroidal Vasculopathy 388
Persistent epithelial defect after penetrating keratoplasty caused by adenoviral infectious keratitis 386
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 382
Evaluation of fixation stability using different targets with the MP1 microperimeter 377
Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration 360
Monolateral Corectopia: considerations about associated myopia. A case report. 356
Indocyanine green angiography and optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration 327
L’epidemiologia del glaucoma 322
Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population 320
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization 310
Moorfields Regression Analysis (MRA) and Glaucoma Probability Score (GPS) Agreement in Daily Clinical Practice 306
Towards the application of precision medicine in age-related macular degeneration 295
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: The RETAIN study 273
The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A. 261
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 240
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial 218
Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness 212
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 197
Ultrasound-Guided Vacuum-Assisted Biopsy in Small Breast: A Cost-Saving Solution 196
Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa 189
Platelet-rich plasma as treatment for persistent ocular epithelial defects 152
Thickness mapping of individual retinal layers and sectors by Spectralis Spectral Domain-optical Coherence Tomography in Autosomal Dominant Optic Atrophy 78
A cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up 77
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials 77
Definition of indicators of appropriateness in the management of neovascular age-related macular degeneration: An expert opinion 74
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data 74
Antimicrobial activity on contact lenses contaminated with planktonic and sessile forms of bacteria: An experimental approach 72
Optical coherence tomography angiography in the multimodal assessment of the retinal posterior pole in autosomal dominant optic atrophy 69
Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (pride study) 68
Aflibercept in persistent neovascular AMD: Comparison of different treatment strategies in switching therapy 67
Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets 65
Genetic determinants highlight the existence of shared etiopathogenetic mechanisms characterizing age-related macular degeneration and neurodegenerative disorders 61
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases 58
An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification 55
Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study 50
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration 48
Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE study 46
Neovascular age-related macular degeneration: Therapeutic management and new-upcoming approaches 46
Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach 45
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial 44
Paper card-like electrochemical platform as a smart point-of-care device for reagent-free glucose measurement in tears 42
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 42
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 41
Longitudinal Structural and Functional Evaluation of Dark-without-Pressure Fundus Lesions in Patients with Autoimmune Diseases 40
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 28
Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries (Eye, (2023), 37, 16, (3351-3359), 10.1038/s41433-023-02540-w) 23
Totale 23.782
Categoria #
all - tutte 56.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.367 0 0 0 0 0 329 341 332 92 115 125 33
2021/2022703 14 42 46 26 12 55 120 30 36 53 83 186
2022/2023962 105 81 24 100 104 211 75 93 84 2 60 23
2023/20241.066 91 45 70 71 99 172 88 60 70 72 49 179
2024/20252.751 132 428 270 145 150 191 247 204 276 205 291 212
2025/20261.787 395 159 458 413 290 72 0 0 0 0 0 0
Totale 23.782